IP6K Inhibitors
ES3084523T3Undetermined Publication Date: 2026-11-13TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ES2018723386T
- Authority / Receiving Office
- ES · ES
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-03-30
- Filing Date
- 2018-03-29
- Publication Date
- 2026-11-13
- Estimated Expiration
- 2038-03-29
Smart Images

Figure 00000041_0000 
Figure 00000042_0000 
Figure 00000043_0000
Abstract
The present invention aims to provide a heterocyclic compound with IP6K inhibitory action, which is expected to be useful as a prophylactic or therapeutic agent for diseases such as heart failure, diabetes, and other similar conditions. A compound represented by formula (I): where each symbol is defined in the SPECIFICATION, or a salt thereof, has IP6K inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for diseases such as heart failure, diabetes, and other similar conditions.
Need to check novelty before this filing date? Find Prior Art
